Literature DB >> 35187623

ASO Author Reflections: Prognostic Index after Neoadjuvant Chemotherapy (PINC) in Pancreatic Ductal Adenocarcinoma as Novel Tumor Regression Grading System.

Miriam Redegalli1,2, Marco Schiavo Lena3,4.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35187623     DOI： 10.1245/s10434-022-11461-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  3 in total

1.  Management of isolated recurrence after surgery for pancreatic adenocarcinoma.

Authors:  Y I Kim; K B Song; Y-J Lee; K-M Park; D W Hwang; J H Lee; S H Shin; J W Kwon; J-S Ro; S C Kim
Journal:  Br J Surg       Date:  2019-06       Impact factor: 6.939

2.  ASO Visual Abstract: Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma.

Authors:  Miriam Redegalli; Marco Schiavo Lena; Maria Giulia Cangi; Chanel Elisha Smart; Martina Mori; Claudio Fiorino; Paolo Giorgio Arcidiacono; Gianpaolo Balzano; Massimo Falconi; Michele Reni; Claudio Doglioni
Journal:  Ann Surg Oncol       Date:  2022-06       Impact factor: 5.344

3.  Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy.

Authors:  Boris V Janssen; Faik Tutucu; Stijn van Roessel; Volkan Adsay; Olca Basturk; Fiona Campbell; Claudio Doglioni; Irene Esposito; Roger Feakins; Noriyoshi Fukushima; Anthony J Gill; Ralph H Hruban; Jeffrey Kaplan; Bas Groot Koerkamp; Seung-Mo Hong; Alyssa Krasinskas; Claudio Luchini; Johan Offerhaus; Arantza Fariña Sarasqueta; Chanjuan Shi; Aatur Singhi; Thomas F Stoop; Eline C Soer; Elizabeth Thompson; Geertjan van Tienhoven; Marie-Louise F Velthuysen; Johanna W Wilmink; Marc G Besselink; Lodewijk A A Brosens; Huamin Wang; Caroline S Verbeke; Joanne Verheij
Journal:  Mod Pathol       Date:  2020-10-12       Impact factor: 7.842
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.